282 related articles for article (PubMed ID: 37079973)
41. Differential putaminal morphology in Huntington's disease, frontotemporal dementia and Alzheimer's disease.
Looi JC; Rajagopalan P; Walterfang M; Madsen SK; Thompson PM; Macfarlane MD; Ching C; Chua P; Velakoulis D
Aust N Z J Psychiatry; 2012 Dec; 46(12):1145-58. PubMed ID: 22990433
[TBL] [Abstract][Full Text] [Related]
42. Recall and Recognition Discriminability in Parkinson's Disease and Huntington's Disease.
Van Etten EJ; Graves LV; Taylor B; Holden HM; Lopez FV; Williams ME; Pirogovsky-Turk E; Corey-Bloom J; Filoteo JV; Delis DC; Gilbert PE
J Huntingtons Dis; 2019; 8(4):459-465. PubMed ID: 31476164
[TBL] [Abstract][Full Text] [Related]
43. Attentional deficits in Alzheimer's, Parkinson's, and Huntington's diseases.
Claus JJ; Mohr E
Acta Neurol Scand; 1996 May; 93(5):346-51. PubMed ID: 8800345
[TBL] [Abstract][Full Text] [Related]
44. Impaired ideomotor limb apraxia in cortical and subcortical dementia: a comparison of Alzheimer's and Huntington's disease.
Holl AK; Ille R; Wilkinson L; Otti DV; Hödl E; Herranhof B; Reisinger KM; Müller N; Painold A; Holl EM; Letmaier M; Bonelli RM
Neurodegener Dis; 2011; 8(4):208-15. PubMed ID: 21212634
[TBL] [Abstract][Full Text] [Related]
45. Clinical Determinants of Dual Tasking in People With Premanifest Huntington Disease.
Reyes A; Bartlett DM; Rankin TJ; Zaenker P; Turner K; Teo WP; Fu SC; Domingos J; Georgiou-Karistianis N; Ziman M; Cruickshank TM
Phys Ther; 2021 Apr; 101(4):. PubMed ID: 33482001
[TBL] [Abstract][Full Text] [Related]
46. The Alzheimer's Prevention Initiative Composite Cognitive Test: a practical measure for tracking cognitive decline in preclinical Alzheimer's disease.
Langbaum JB; Ellison NN; Caputo A; Thomas RG; Langlois C; Riviere ME; Graf A; Lopez Lopez C; Reiman EM; Tariot PN; Hendrix SB
Alzheimers Res Ther; 2020 May; 12(1):66. PubMed ID: 32460855
[TBL] [Abstract][Full Text] [Related]
47. Cognitive and functional decline in African Americans with VaD, AD, and stroke without dementia.
Nyenhuis DL; Gorelick PB; Freels S; Garron DC
Neurology; 2002 Jan; 58(1):56-61. PubMed ID: 11781406
[TBL] [Abstract][Full Text] [Related]
48. Methylphenidate and galantamine in patients with vascular cognitive impairment-the proof-of-principle study STREAM-VCI.
Leijenaar JF; Groeneveld GJ; Klaassen ES; Leeuwis AE; Scheltens P; Weinstein HC; van Gerven JMA; Barkhof F; van der Flier WM; Prins ND
Alzheimers Res Ther; 2020 Jan; 12(1):10. PubMed ID: 31910895
[TBL] [Abstract][Full Text] [Related]
49. Alzheimer's Disease and Parkinson Dementia Distinguished by Cognitive Marker.
Kozlova I; Parra MA; Titova N; Gantman M; Sala SD
Arch Clin Neuropsychol; 2021 Apr; 36(3):307-315. PubMed ID: 32101280
[TBL] [Abstract][Full Text] [Related]
50. Sex ratio in dementia with Lewy bodies balanced between Alzheimer's disease and Parkinson's disease dementia: a cross-sectional study.
Mouton A; Blanc F; Gros A; Manera V; Fabre R; Sauleau E; Gomez-Luporsi I; Tifratene K; Friedman L; Thümmler S; Pradier C; Robert PH; David R
Alzheimers Res Ther; 2018 Sep; 10(1):92. PubMed ID: 30208961
[TBL] [Abstract][Full Text] [Related]
51. Motor subtype and cognitive decline in Parkinson's disease, Parkinson's disease with dementia, and dementia with Lewy bodies.
Burn DJ; Rowan EN; Allan LM; Molloy S; O'Brien JT; McKeith IG
J Neurol Neurosurg Psychiatry; 2006 May; 77(5):585-9. PubMed ID: 16614017
[TBL] [Abstract][Full Text] [Related]
52. Exploring eye movements of Parkinson's disease patients performing the Judgement of line orientation test.
Alamri Y; Dalrymple-Alford J; MacAskill M; Anderson TJ
J Clin Neurosci; 2020 Jun; 76():183-188. PubMed ID: 32331938
[TBL] [Abstract][Full Text] [Related]
53. Comparison of dementia with Lewy bodies to Alzheimer's disease and Parkinson's disease with dementia.
Noe E; Marder K; Bell KL; Jacobs DM; Manly JJ; Stern Y
Mov Disord; 2004 Jan; 19(1):60-7. PubMed ID: 14743362
[TBL] [Abstract][Full Text] [Related]
54. Validation Study of a German Cognitive Battery for Huntington's Disease: Relationship Between Cognitive Performance, Functional Decline, and Disease Burden.
Mühlbäck A; Frank W; Klempířová O; Bezdíček O; Schmitt L; Hofstetter N; Landwehrmeyer GB; Klempíř J
Arch Clin Neuropsychol; 2021 Jan; 36(1):74-86. PubMed ID: 32613239
[TBL] [Abstract][Full Text] [Related]
55. Hospital-treated infections in early- and mid-life and risk of Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis: A nationwide nested case-control study in Sweden.
Sun J; Ludvigsson JF; Ingre C; Piehl F; Wirdefeldt K; Zagai U; Ye W; Fang F
PLoS Med; 2022 Sep; 19(9):e1004092. PubMed ID: 36107840
[TBL] [Abstract][Full Text] [Related]
56. Computerized testing in Parkinson's disease: Performance deficits in relation to standard clinical measures.
Flannery SL; Jowett T; Garvey A; Cutfield NJ; Machado L
J Clin Exp Neuropsychol; 2018 Dec; 40(10):1062-1073. PubMed ID: 29978753
[TBL] [Abstract][Full Text] [Related]
57. Cognitive-behavioral profiles of neurodegenerative dementias: beyond Alzheimer's disease.
Levy JA; Chelune GJ
J Geriatr Psychiatry Neurol; 2007 Dec; 20(4):227-38. PubMed ID: 18004009
[TBL] [Abstract][Full Text] [Related]
58. Cognitive, global, and functional benefits of donepezil in Alzheimer's disease and vascular dementia: results from large-scale clinical trials.
Passmore AP; Bayer AJ; Steinhagen-Thiessen E
J Neurol Sci; 2005 Mar; 229-230():141-6. PubMed ID: 15760632
[TBL] [Abstract][Full Text] [Related]
59. Compensating for verbal-motor deficits in neuropsychological assessment in movement disorders: sensitivity and specificity of the ECAS in Parkinson's and Huntington's diseases.
Carelli L; Solca F; Migliore S; Torre S; Brugnera A; Mancini F; Tagini S; Ferrucci R; Maffi S; Ceccarelli C; Pasquini J; Sassone J; Squitieri F; Ciammola A; Silani V; Poletti B
Neurol Sci; 2021 Dec; 42(12):4997-5006. PubMed ID: 33728549
[TBL] [Abstract][Full Text] [Related]
60. Prospective comparative study of the evolution of probable Alzheimer's disease and Parkinson's disease dementia.
Stern Y; Tang MX; Jacobs DM; Sano M; Marder K; Bell K; Dooneief G; Schofield P; Côté L
J Int Neuropsychol Soc; 1998 May; 4(3):279-84. PubMed ID: 9623002
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
